Study of Motexafin Gadolinium for the Treatment of Non-Hodgkin's Lymphoma
The primary purpose of this study is to find out if motexafin gadolinium may be an effective treatment for patients with non-Hodgkin's lymphoma (NHL). Secondly, the safety and side effects of motexafin gadolinium will be evaluated.
Lymphoma|Non-Hodgkin's Lymphoma
DRUG: Motexafin gadolinium
Clinical response rate
Progression-free survival|Duration of clinical response|Safety and tolerability
The primary purpose of this study is to find out if motexafin gadolinium may be an effective treatment for patients with non-Hodgkin's lymphoma (NHL). Secondly, the safety and side effects of motexafin gadolinium will be evaluated.